CX157

http://dbpedia.org/resource/CX157 an entity of type: Thing

CX157 (proposed trade name TriRima, formerly Tyrima) is a selective and reversible inhibitor of MAO-A (RIMA). As of 2007 it was in phase II clinical trials for the treatment of depression. In 2013, work on the drug was terminated.[1] rdf:langString
rdf:langString CX157
xsd:integer 23042014
xsd:integer 1120071400
rdf:langString none
xsd:integer 14
xsd:integer 205187
xsd:integer 13701383
xsd:integer 4
xsd:integer 8
xsd:integer 3
rdf:langString Uncontrolled
xsd:integer 4
xsd:integer 18687754
rdf:langString Oral
xsd:integer 1
rdf:langString FCCOc2cc3Oc1ccccc1Sc3cc2
xsd:integer 1
rdf:langString PDIMOTRDGUQMNY-UHFFFAOYSA-N
rdf:langString O6L62LZJ0Q
xsd:integer 396516252
rdf:langString CX157 (proposed trade name TriRima, formerly Tyrima) is a selective and reversible inhibitor of MAO-A (RIMA). As of 2007 it was in phase II clinical trials for the treatment of depression. In 2013, work on the drug was terminated.[1]
xsd:nonNegativeInteger 2470
xsd:string 205187-53-7
xsd:string O6L62LZJ0Q
xsd:string 18687754
owl:Thing
<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject>
dbpedia-owl:ChemicalSubstance
<http://www.wikidata.org/entity/Q8386>
yago:WikicatMonoamineOxidaseInhibitors
yago:Agent114778436
yago:Antidepressant102718811
yago:CausalAgent100007347
yago:Drug103247620
yago:Matter100020827
yago:Medicine103740161
yago:MonoamineOxidaseInhibitor103783017
yago:PhysicalEntity100001930
dbpedia-owl:Drug
yago:Substance100020090
<http://commons.wikimedia.org/wiki/Special:FilePath/CX157_structure.svg>
<http://dbpedia.org/resource/Category:Sulfones>
<http://dbpedia.org/resource/Category:Reversible_inhibitors_of_MAO-A>
<http://dbpedia.org/resource/Category:Abandoned_drugs>
<http://dbpedia.org/resource/Category:Fluoroarenes>
<http://dbpedia.org/resource/Category:Sulfur_heterocycles>
<http://dbpedia.org/resource/Category:Trifluoromethyl_compounds>
<http://dbpedia.org/resource/Category:Monoamine_oxidase_inhibitors>
<http://dbpedia.org/resource/Category:Sulfones>
<http://dbpedia.org/resource/Category:Reversible_inhibitors_of_MAO-A>
<http://dbpedia.org/resource/Reversible_inhibitor_of_monoamine_oxidase_A>
<http://dbpedia.org/resource/Category:Abandoned_drugs>
<http://dbpedia.org/resource/Category:Fluoroarenes>
<http://dbpedia.org/resource/Category:Sulfur_heterocycles>
<http://dbpedia.org/resource/Category:Trifluoromethyl_compounds>
<http://dbpedia.org/resource/Clinical_depression>
<http://dbpedia.org/resource/Clinical_trial>
<http://dbpedia.org/resource/Category:Monoamine_oxidase_inhibitors>
<http://dbpedia.org/resource/Binding_selectivity>
<http://dbpedia.org/resource/Phases_of_clinical_research>
<http://adisinsight.springer.com/drugs/800025697>
<http://rdf.freebase.com/ns/m.064mnt4>
<http://yago-knowledge.org/resource/CX157>
<http://www.wikidata.org/entity/Q5014870>
<http://sh.dbpedia.org/resource/CX157>
<http://sr.dbpedia.org/resource/CX157>
<https://global.dbpedia.org/id/4e77V>
<http://dbpedia.org/resource/Template:Drugbox>
<http://dbpedia.org/resource/Template:Nervous-system-drug-stub>
<http://dbpedia.org/resource/Template:Reflist>
<http://dbpedia.org/resource/Template:Short_description>
<http://dbpedia.org/resource/Template:Cascite>
<http://dbpedia.org/resource/Template:Chemspidercite>
<http://dbpedia.org/resource/Template:Fdacite>
<http://dbpedia.org/resource/Template:Stdinchicite>
<http://dbpedia.org/resource/Template:Monoamine_metabolism_modulators>
<http://commons.wikimedia.org/wiki/Special:FilePath/CX157_structure.svg?width=300>
<http://dbpedia.org/resource/Inhibitor>
<http://en.wikipedia.org/wiki/CX157?oldid=1120071400&ns=0>
<http://en.wikipedia.org/wiki/CX157>

data from the linked data cloud